Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

Alessandra De Remigis, Tanja D. De Gruijl, Jennifer N. Uram, Shey-Cherng Tzou, Shintaro Iwama, Monica V. Talor, Todd D. Armstrong, Saskia J.A.M. Santegoets, Susan F. Slovin, Lei Zheng, Daniel A. Laheru, Elizabeth M. Jaffee, Winald R. Gerritsen, Alfons J.M. Van Den Eertwegh, Dung T. Le, Patrizio Caturegli*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival'. Together they form a unique fingerprint.

Medicine & Life Sciences